Roxybond

Acute Pain, Pain, Pain + 2 more
Treatment
5 FDA approvals
0 Active Studies for Roxybond

What is Roxybond

OxycodoneThe Generic name of this drug
Treatment SummaryOxycodone is a type of painkiller derived from thebaine, a naturally occurring opioid. It is used to treat moderate to severe pain on a short-term or long-term basis. The first oxycodone product, Percodan, was approved by the FDA in 1950.
Percodanis the brand name
Roxybond Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Percodan
Oxycodone
1950
822

Approved as Treatment by the FDA

Oxycodone, otherwise called Percodan, is approved by the FDA for 5 uses like Pain and Pain .
Pain
Used to treat Severe Pain in combination with Acetaminophen
Pain
Helps manage Severe, Chronic Pain
Pain
Helps manage chronic, moderate Pain
Acute Pain
Helps manage acute, moderate Pain
Pain
Helps manage severe Pain, Acute

Effectiveness

How Roxybond Affects PatientsOxycodone has effects on many parts of the body, including the brain stem, cough reflex, pupils, digestive system, blood vessels, hormones, and immune system. It can cause breathing to slow down, decrease the size of the pupils, slow digestion and cause constipation, cause itching, red eyes, flushing and sweating, change hormone levels, and possibly affect the immune system.
How Roxybond works in the bodyOxycodone works by targeting opioid receptors in your body, specifically in the brain, heart, lungs, liver, gastrointestinal tract, and reproductive system. These receptors are increased in conditions of inflammation or pain. Oxycodone and its active metabolites bind to these receptors and activate a G protein-coupled receptor signaling pathway. This pathway blocks N-type voltage operated calcium channels and stops your body from responding to pain.

When to interrupt dosage

The proposed measure of Roxybond is contingent upon the diagnosed condition, such as severe, average Pain, Pain and Pain. The exact quantity of dosage fluctuates, in accordance with the method of delivery (e.g. Concentrate - Oral or Oral) referenced in the table beneath.
Condition
Dosage
Administration
Acute Pain
, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL
, Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Concentrate, Concentrate - Oral
Pain
, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL
, Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Concentrate, Concentrate - Oral
Pain
, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL
, Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Concentrate, Concentrate - Oral
Pain
, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL
, Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Concentrate, Concentrate - Oral
Pain
, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL
, Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Concentrate, Concentrate - Oral

Warnings

Roxybond Contraindications
Condition
Risk Level
Notes
Intestinal Obstruction
Do Not Combine
Paralytic Ileus
Do Not Combine
Intestinal Pseudo-Obstruction
Do Not Combine
Intestinal Obstruction
Do Not Combine
Mental Depression
Do Not Combine
Asthma
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Oxycodone may interact with Pulse Frequency
There are 20 known major drug interactions with Roxybond.
Common Roxybond Drug Interactions
Drug Name
Risk Level
Description
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Oxycodone.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Oxycodone.
Azelastine
Major
Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Oxycodone.
Carbamazepine
Major
The metabolism of Carbamazepine can be decreased when combined with Oxycodone.
Roxybond Toxicity & Overdose RiskTaking too much oxycodone can lead to breathing problems, drowsiness, unconsciousness, weak muscles, cold sweats, small pupils, slow heartbeat, low blood pressure, difficulty breathing, snoring, and even death. Treatment includes maintaining airways and oxygen levels, using oxygen and medication to treat shock and fluid in the lungs, and using drugs such as Naloxone to counteract the effects of opioids. Pregnant women should use caution when taking oxycodone as animal studies have shown smaller offspring with lactation. Oxycodone is not known to cause cancer, but has been found to be genotoxic in some tests

Roxybond Novel Uses: Which Conditions Have a Clinical Trial Featuring Roxybond?

No active clinical trials are currently being conducted to investigate the ability of Roxybond to provide relief from acute, moderate Pain and Pain.
Condition
Clinical Trials
Trial Phases
Acute Pain
0 Actively Recruiting
Pain
0 Actively Recruiting
Pain
0 Actively Recruiting
Pain
0 Actively Recruiting
Pain
0 Actively Recruiting

Patient Q&A Section about roxybond

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security